MYM Nutraceuticals Inc. (MYMMF)

0.0941 +0.0030 (+3.25%) At close: 3:55PM EST

MYM Nutraceuticals Inc.

409 West Pender Street
Suite 1500
Vancouver, BC V6E 2M6
Canada
778 522 2261
http://www.mym.ca

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Mark G. Forster	Chief Financial Officer	N/A	N/A	N/A
Mr. Robin Linden	Exec. VP, Chief Marketing Officer & Director	N/A	N/A	N/A
Mr. Michael Wiener	CEO & Director	N/A	N/A	N/A
Mr. James Andrews	VP of Operations	N/A	N/A	N/A
Mr. Billy Casselman	VP of Commercial Sales & Investor Relations	N/A	N/A	N/A
Ms. Fiona Orr	Legal Counsel	N/A	N/A	N/A
Matthew Simms	Head of Sales	N/A	N/A	N/A
Mr. Laird Choi	Exec. VP of Corp. Services	N/A	N/A	N/A
Sheryl Dhillon	Corp. Sec.	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MYM Nutraceuticals Inc. cultivates, processes, and sells cannabis in Canada. The company was formerly known as My Marijuana Canada Inc. and changed its name to MYM Nutraceuticals Inc. in February 2016. MYM Nutraceuticals Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.

Corporate Governance

MYM Nutraceuticals Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.